Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
We offer We offer a Principal Investigator position where you will lead your innovative, technology-focused research line, expand the department's computational core, and drive large-scale, data
-
well as, if necessary, supervise students at both master's and doctoral level Eligibility The eligibility criteria for employing teaching staff are set out in Chapter 4 of the Higher Education Ordinance and in
-
step to advance your research training. Click here to learn more about our Postdoctoral Program and Services: https://education.scripps.edu/postdoctoral/ REQUIREMENTS: Must possess a doctoral degree. A
-
will be part of the journal launch team and play a key role in shaping, developing, and establishing the journal from the very beginning. Handle original research papers and work closely with editorial
-
include: Handling original research papers, and working closely with other editors on all aspects of the editorial process, including manuscript selection and overseeing peer review. Making well-reasoned
-
on the application, reference check and interview. Terms of employment The employment is expected to result in a doctoral degree and the main assignment for the doctoral student is thus to be part of the research
-
English as the primary language. Career development support and mentoring throughout the program. Interdisciplinary coursework and research opportunities across different areas of science, engineering and
-
consists of the head of 'EvoMoRG', a lab manager, three postdocs, five Doctoral, 13 Master, and five Bachelor students. As a university assistant predoctoral (Doctoral student), you conduct a research
-
encourages diversity. THE INSTITUTE: The European Synchrotron Radiation Facility (ESRF): https://www.esrf.fr/home.html is a world-leading international scientific research infrastructure supported by nineteen
-
Infectious Disease Institute has a longstanding commitment to HIV Cure research and has recently added a focus areas on SARS-CoV-2 (including Long COVID), mRNA vaccines, and phage therapy. Primary criteria